Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Wang, Nan ^a,b   Li, Qinggang ^a   Zhang, Li ^a   Lin, Hongli ^c   Hu, Jie ^a   Li, Diangeng ^a   Shi, Suozhu ^a   Cui, Shaoyuan ^a   Zhou, Jianhui ^a   Ji, Jiayao ^a,b   Wan, Jiajia ^a,b   Cai, Guangyan ^a   Chen, Xiangmei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NANKAI UNIVERSITY   (China)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN TSG 6; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; CONDITIONED MEDIUM; TNFAIP6 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL DAMAGE; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CELL THERAPY; CONTROLLED STUDY; FIBROBLAST; IN VIVO STUDY; MACROPHAGE; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESOTHELIUM CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEAL FIBROSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; RNA INTERFERENCE; STOMACH BIOPSY; THERAPY EFFECT; ANIMAL; CELL MOTION; COCULTURE; CONDITIONED MEDIUM; CONFOCAL MICROSCOPY; DRUG EFFECTS; EPITHELIUM CELL; GENETICS; IMMUNOHISTOCHEMISTRY; INJURIES; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; PERITONEUM; PHARMACOLOGY; PROCEDURES; SECRETION (PROCESS); SPRAGUE DAWLEY RAT; SURGERY; TIME FACTOR; TISSUE ADHESIONS;

ANIMALS; CELL ADHESION MOLECULES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICROSCOPY, CONFOCAL; PERITONEAL FIBROSIS; PERITONEUM; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; TIME FACTORS; TISSUE ADHESIONS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84865088636     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043768     Document Type: Article

References (51)

1. Herrick SE, Mutsaers SE, (2004) Mesothelial progenitor cells and their potential in tissue engineering. Int J Biochem Cell Biol 36:: 621-642.
2. Aroeira LS, Aguilera A, Sanchez-Tomero JA, Bajo MA, del Peso G, et al. (2007) Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 18:: 2004-2013.
3. Saxena R, (2008) Pathogenesis and treatment of peritoneal membrane failure. Pediatr Nephrol 23:: 695-703.
4. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, et al. (2002) Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13:: 470-479.
5. Williams JD, Craig KJ, von Ruhland C, Topley N, Williams GT (2003) The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl: S43-49.
6. Guo Q, Li QF, Liu HJ, Li R, Wu CT, et al. (2008) Sphingosine kinase 1 gene transfer reduces postoperative peritoneal adhesion in an experimental model. Br J Surg 95:: 252-258.
7. Liu HJ, Wu CT, Duan HF, Wu B, Lu ZZ, et al. (2006) Adenoviral-mediated gene expression of hepatocyte growth factor prevents postoperative peritoneal adhesion in a rat model. Surgery 140:: 441-447.
8. Guo H, Leung JC, Cheung JS, Chan LY, Wu EX, et al. (2009) Non-viral Smad7 gene delivery and attenuation of postoperative peritoneal adhesion in an experimental model. Br J Surg 96:: 1323-1335.
9. Kanazawa H, Fujimoto Y, Teratani T, Iwasaki J, Kasahara N, et al. (2011) Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model. PLoS One 6:: e19195.
10. Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, et al. (2005) Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112:: 1128-1135.
11. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, et al. (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 100:: 8407-8411.
12. Oyagi S, Hirose M, Kojima M, Okuyama M, Kawase M, et al. (2006) Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol 44:: 742-748.
13. Ninichuk V, Gross O, Segerer S, Hoffmann R, Radomska E, et al. (2006) Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 70:: 121-129.
14. Parekkadan B, Milwid JM, (2010) Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12:: 87-117.
15. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:: 143-147.
16. Meirelles Lda S, Fontes AM, Covas DT, Caplan AI, (2009) Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20:: 419-427.
17. Gnecchi M, Zhang Z, Ni A, Dzau VJ, (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:: 1204-1219.
18. Gnecchi M, He H, Liang OD, Melo LG, Morello F, et al. (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11:: 367-368.
19. Mias C, Lairez O, Trouche E, Roncalli J, Calise D, et al. (2009) Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells 27:: 2734-2743.
20. Yoon BS, Moon JH, Jun EK, Kim J, Maeng I, et al. (2010) Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells. Stem Cells Dev 19:: 887-902.
21. Oh JY, Roddy GW, Choi H, Lee RH, Ylostalo JH, et al. (2010) Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc Natl Acad Sci U S A 107:: 16875-16880.
22. Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ, (2011) Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-{kappa}B signaling in resident macrophages. Blood 118:: 330-338.
23. Lauder CI, Garcea G, Strickland A, Maddern GJ, (2011) Use of a modified chitosan-dextran gel to prevent peritoneal adhesions in a rat model. J Surg Res 171:: 877-882.
24. Fang CC, Chou TH, Lin GS, Yen ZS, Lee CC, et al. (2010) Peritoneal infusion with cold saline decreased postoperative intra-abdominal adhesion formation. World J Surg 34:: 721-727.
25. Yung S, Davies M, (1998) Response of the human peritoneal mesothelial cell to injury: an in vitro model of peritoneal wound healing. Kidney Int 54:: 2160-2169.
26. Li L, Zhang Y, Li Y, Yu B, Xu Y, et al. (2008) Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure. Transpl Int 21:: 1181-1189.
27. van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, et al. (2008) Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 47:: 1634-1643.
28. Whang SH, Astudillo JA, Sporn E, Bachman SL, Miedema BW, et al. (2011) In search of the best peritoneal adhesion model: comparison of different techniques in a rat model. J Surg Res 167:: 245-250.
29. Nie J, Dou X, Hao W, Wang X, Peng W, et al. (2007) Smad7 gene transfer inhibits peritoneal fibrosis. Kidney Int 72:: 1336-1344.
30. Yew TL, Hung YT, Li HY, Chen HW, Chen LL, et al. (2011) Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation. Cell Transplant 20:: 693-706.
31. Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, et al. (1995) Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J Clin Invest 95:: 1158-1168.
32. Zangi L, Margalit R, Reich-Zeliger S, Bachar-Lustig E, Beilhack A, et al. (2009) Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells. Stem Cells 27:: 2865-2874.
33. Segura T, Schmokel H, Hubbell JA, (2007) RNA interference targeting hypoxia inducible factor 1alpha reduces post-operative adhesions in rats. J Surg Res 141:: 162-170.
34. Kamel RM, (2010) Prevention of postoperative peritoneal adhesions. Eur J Obstet Gynecol Reprod Biol 150:: 111-118.
35. Cahill RA, Redmond HP, (2008) Cytokine orchestration in post-operative peritoneal adhesion formation. World J Gastroenterol 14:: 4861-4866.
36. Gnecchi M, He H, Melo LG, Noiseaux N, Morello F, et al. (2009) Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells 27:: 971-979.
37. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, et al. (2009) Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:: 54-63.
38. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, et al. (2009) Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18:: 683-692.
39. Lee RH, Seo MJ, Pulin AA, Gregory CA, Ylostalo J, et al. (2009) The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice. Blood 113:: 816-826.
40. Song H, Cha MJ, Song BW, Kim IK, Chang W, et al. (2010) Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Stem Cells 28:: 555-563.
41. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, et al. (2009) Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:: 1053-1067.
42. Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ, (2005) Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci U S A 102:: 18171-18176.
43. Takahashi M, Li TS, Suzuki R, Ito H, Mikamo A, et al. (2005) Cytokines produced from bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes against ischemic injury and inducing therapeutic angiogenesis. Circulation 112:: U321-U321.
44. Lozito TP, Tuan RS, (2011) Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J Cell Physiol 226:: 385-396.
45. Lesley J, Gal I, Mahoney DJ, Cordell MR, Rugg MS, et al. (2004) TSG-6 modulates the interaction between hyaluronan and cell surface CD44. J Biol Chem 279:: 25745-25754.
46. Szanto S, Bardos T, Gal I, Glant TT, Mikecz K, (2004) Enhanced neutrophil extravasation and rapid progression of proteoglycan-induced arthritis in TSG-6-knockout mice. Arthritis Rheum 50:: 3012-3022.
47. Hoshino A, Kawamura YI, Yasuhara M, Toyama-Sorimachi N, Yamamoto K, et al. (2007) Inhibition of CCL1-CCR8 interaction prevents aggregation of macrophages and development of peritoneal adhesions. J Immunol 178:: 5296-5304.
48. Mindrescu C, Le J, Wisniewski HG, Vilcek J, (2005) Up-regulation of cyclooxygenase-2 expression by TSG-6 protein in macrophage cell line. Biochem Biophys Res Commun 330:: 737-745.
49. Selbi W, Day AJ, Rugg MS, Fulop C, de la Motte CA, et al. (2006) Overexpression of hyaluronan synthase 2 alters hyaluronan distribution and functSoc Nephrol 17: 1553-1567.
50. Evanko SP, Tammi MI, Tammi RH, Wight TN, (2007) Hyaluronan-dependent pericellular matrix. Adv Drug Deliv Rev 59: 1351-1365.
51. Al'Qteishat A, Gaffney J, Krupinski J, Rubio F, West D, et al. (2006) Changes in hyaluronan production and metabolism following ischaemic stroke in man. Brain 129: 2158-2176.